JPH02138268A - Benzoxazine compound - Google Patents

Benzoxazine compound

Info

Publication number
JPH02138268A
JPH02138268A JP20544089A JP20544089A JPH02138268A JP H02138268 A JPH02138268 A JP H02138268A JP 20544089 A JP20544089 A JP 20544089A JP 20544089 A JP20544089 A JP 20544089A JP H02138268 A JPH02138268 A JP H02138268A
Authority
JP
Japan
Prior art keywords
difluoro
chloroform
benzoxazine
residue
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP20544089A
Other languages
Japanese (ja)
Other versions
JPH0331710B2 (en
Inventor
Isao Hayakawa
勇夫 早川
Yoshiaki Tanaka
良明 田中
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Priority to JP20544089A priority Critical patent/JPH02138268A/en
Publication of JPH02138268A publication Critical patent/JPH02138268A/en
Publication of JPH0331710B2 publication Critical patent/JPH0331710B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

NEW MATERIAL:A benzoxazine compound of the formula (R1 is lower alkyl). EXAMPLE:Diethyl (7,8-difluoro-3-methoxymethyl-2,3-dihydro-4H-1,4-benzoxazin-4-yl) methylmalonate. USE:It is used as a starting substance for synthesizing pyrido[1,2,3-de] [1,4]benzoxazine derivative, an antibacterial agent. PREPARATION:For example, 1-(2,3-difluoro-6-nitrophenoxy)-3-methoxy 2- propanone is dissolved in ethanol and catalytically hydrogenated in the presence of a Raney nickel. Then, the oily product is combined with diethyl malonate, heated, then cooled down, and the product is purified by means of chromatography to obtain the compound exemplified in the formula.

Description

【発明の詳細な説明】 産業 の 本発明は抗菌性化合物の原料として有用な化合物に関す
る。
DETAILED DESCRIPTION OF THE INVENTION This invention relates to compounds useful as raw materials for antimicrobial compounds.

一見豆立盗五一 本発明はく7.8−ジフルオロ−3−メトキシメチル−
2,3−ジヒドロ−4)1−1.4−ベンゾオキサジン
−4−イル)メチレンマロン酸ジ低級アルキルエステル
に関し、このものはピリド[1,2,3−del [1
,41ベンゾオキサジン誘導体の製造原料として有用で
ある。
At first glance, the present invention is 7.8-difluoro-3-methoxymethyl-
2,3-dihydro-4)1-1.4-benzoxazin-4-yl)methylene malonic acid di-lower alkyl ester, which is a pyrido[1,2,3-del[1
, 41 is useful as a raw material for producing benzoxazine derivatives.

本発明化合物の製造法を実施例で説明する。The method for producing the compound of the present invention will be explained in Examples.

実施例 1− (2,3−ジフルオロ−6−二トロフエノキシ)
−3−メトキシ−2−プロパノン9.5gをエタノール
100m1に溶かし、ラネー・ニッケル10+slを加
えて常圧で接触還元した。触媒を濾去し、溶媒を減圧留
去後残渣をシリカゲルカラムクロマトグラフィで精製し
て油状物3.98を得た。この油状物3.08にエトキ
シメチレンマロン酸ジエチル3.5gを加えて浴温10
5〜115℃で2時間加熱した。冷後、反応物をシリカ
ゲルカラムクロマトグラフィで精製し融点81℃の(7
,8−ジフルオロ−3−メトキシメチル−2,3−ジヒ
ドロ−48−1,4−ベンゾオキサジン−4−イル)メ
チレンマロン酸ジエチル4.1gを得た。
Example 1- (2,3-difluoro-6-nitrophenoxy)
9.5 g of -3-methoxy-2-propanone was dissolved in 100 ml of ethanol, 10+ sl of Raney nickel was added, and catalytic reduction was carried out at normal pressure. The catalyst was filtered off, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography to obtain 3.98% of an oil. Add 3.5 g of diethyl ethoxymethylenemalonate to 3.08 g of this oil, and add the bath temperature to 10 g.
Heated at 5-115°C for 2 hours. After cooling, the reaction product was purified by silica gel column chromatography to obtain a solution with a melting point of 81°C (7
, 8-difluoro-3-methoxymethyl-2,3-dihydro-48-1,4-benzoxazin-4-yl)methylenemalonate (4.1 g) was obtained.

元素分析値 C5a)12+FzNOsとして計算値 
C56,1G、 H5,49,N 3.64分析値 C
56,25,H5,4フ、 N 3.74参考例1 2.3−ジフルオロ−6−二トロフエノール7.0g、
エピクロルヒドリン7.0g、炭酸カリウム 15g及
びヨウ化カリウム600mgをジメチルホルムアミド 
150m1に加え、浴温85〜90℃で20時間攪拌す
る。冷後、不溶物を濾去し、濾液を減圧濃縮して残渣を
クロロホルムと水で分配する。クロロホルム層は水洗し
、芒硝で乾燥後、溶媒を留去して残漬をシリカゲルカラ
ムクロマトグラフィで精製し淡黄色油状物として2.3
−ジフルオロ−6−二トロフエニル・オキシラニルメチ
ル・エーテル6.1gを得た。
Elemental analysis value C5a) Calculated value as 12+FzNOs
C56,1G, H5,49,N 3.64 analysis value C
56,25,H5,4 ph, N 3.74 Reference example 1 2.3-difluoro-6-nitrophenol 7.0 g,
7.0 g of epichlorohydrin, 15 g of potassium carbonate, and 600 mg of potassium iodide were dissolved in dimethylformamide.
150ml and stirred for 20 hours at a bath temperature of 85-90°C. After cooling, insoluble matters were removed by filtration, the filtrate was concentrated under reduced pressure, and the residue was partitioned between chloroform and water. The chloroform layer was washed with water, dried with Glauber's salt, the solvent was distilled off, and the residue was purified by silica gel column chromatography to give a pale yellow oil (2.3).
6.1 g of -difluoro-6-nitrophenyl oxiranylmethyl ether was obtained.

この化合物15.0gおよび第二塩化スズ0.3mlを
無水メタノール80m1に加えて2時間還流する。溶媒
を留去し残漬をクロロホルムと水で分配し、クロロホル
ム層より、油状物として!−(2,3−ジフルオロ−6
−ニトロフェノキシ)−3−メトキシ−2−プロパツー
ル11i、1gを得た。
15.0 g of this compound and 0.3 ml of stannic chloride were added to 80 ml of anhydrous methanol, and the mixture was refluxed for 2 hours. The solvent is distilled off and the residue is distributed between chloroform and water, and from the chloroform layer, an oil is obtained! -(2,3-difluoro-6
-Nitrophenoxy)-3-methoxy-2-propatool 11i, 1 g was obtained.

この化合物15gをアセトン150m1にとかし、水冷
下、攪拌しつつジョーンズ試薬(無水クロム酸32g、
水64m1、濃硫酸16m1から調製) 50m1を滴
下し同温度で30分、次いで室温で2時間攪拌する。不
溶物を除去し、アセトン、次いでクロロホルムで洗って
、濾液及び洗液を合わせ溶媒を留去する。
15 g of this compound was dissolved in 150 ml of acetone, and while stirring under water cooling, Jones reagent (chromic anhydride 32 g,
50 ml (prepared from 64 ml of water and 16 ml of concentrated sulfuric acid) was added dropwise and stirred at the same temperature for 30 minutes, then at room temperature for 2 hours. Insoluble matters were removed, washed with acetone and then with chloroform, the filtrate and washing liquid were combined, and the solvent was distilled off.

残漬はクロロホルムと水で分配し、クロロホルム層を水
洗し、芒硝で乾燥後クロロホルムを留去する。残漬をシ
リカゲルカラムクロマトグラフィで精製し、クロロホル
ム溶出液から融点39〜42℃の1− (2,3−ジフ
ルオロ−6−ニトロフェノキシ)−3−メトキシ−2−
プロパノン10.6gを得た。
The remaining residue is divided between chloroform and water, the chloroform layer is washed with water, dried over sodium sulfate, and the chloroform is distilled off. The residue was purified by silica gel column chromatography, and 1-(2,3-difluoro-6-nitrophenoxy)-3-methoxy-2- with a melting point of 39-42°C was obtained from the chloroform eluate.
10.6 g of propanone was obtained.

参考例2 (7,8−ジフルオロ−3−メトキシメチル−2,3−
ジヒドロ−48−1,4−ベンゾオキサジン−4−イル
)メチレンマロン酸ジエチル3.0gをポリリン酸エチ
ル208に加えて浴温120〜125℃で1.5時間加
熱する。冷後、氷水を加え、析出物をクロロホルムで抽
出する。抽出液は水洗し、芒硝乾燥後溶媒を留去する。
Reference example 2 (7,8-difluoro-3-methoxymethyl-2,3-
3.0 g of diethyl dihydro-48-1,4-benzoxazin-4-yl)methylenemalonate is added to ethyl polyphosphate 208 and heated at a bath temperature of 120 to 125°C for 1.5 hours. After cooling, ice water is added and the precipitate is extracted with chloroform. The extract is washed with water, dried over sodium sulfate, and then the solvent is distilled off.

残漬をシリカゲルカラムクロマトグラフィで精製し、ク
ロロホルム溶出分から得られる粉末を、ジクロルメタン
とイソプロピルエーテルの混液から再結晶して融点23
8℃の徴針晶とじて9.10−ジフルオロ−3−メトキ
シメチル−7−オキソ−2,3−ジヒドロ−7H−とリ
ド[1、2、3−del [1、4] ベンゾオキサジ
ン−6−カルボン酸エチル1.7gを得た。
The residue was purified by silica gel column chromatography, and the powder obtained from the chloroform eluate was recrystallized from a mixture of dichloromethane and isopropyl ether to a melting point of 23.
9.10-difluoro-3-methoxymethyl-7-oxo-2,3-dihydro-7H- and lido[1,2,3-del[1,4]benzoxazine-6 at 8°C. -1.7 g of ethyl carboxylate was obtained.

上記化合物1.7gをジクロルメタン100m1に加え
て水冷下に臭化アルミニウム6.0gをエタンチオール
10m1に溶かした溶液を滴下する。室温にもどして3
時間攪拌したのち、溶媒を留去し、残漬に氷水を加えて
不溶物を濾取する。得られた白色粉末をクロロホルムと
エタノールの混液から再結晶して融点268〜270℃
の徴針晶として9.lQ−ジフルオロ−3−ヒドロキシ
メチル−7−オキソ−2,3−ジヒド0−7H−ピリド
[1,2,3−del [1,4] ベンゾオキサジン
−6−カルボン酸エチル1.18を得た。
1.7 g of the above compound was added to 100 ml of dichloromethane, and a solution of 6.0 g of aluminum bromide dissolved in 10 ml of ethanethiol was added dropwise while cooling with water. Return to room temperature 3
After stirring for an hour, the solvent is distilled off, ice water is added to the residue, and insoluble matter is filtered off. The obtained white powder was recrystallized from a mixture of chloroform and ethanol to a melting point of 268-270°C.
9. As a needle crystal. lQ-difluoro-3-hydroxymethyl-7-oxo-2,3-dihydro0-7H-pyrido[1,2,3-del[1,4] ethyl benzoxazine-6-carboxylate 1.18 was obtained .

上記化合物400mgをクロロホルム30m1に溶かし
これに塩化チオニル3mlを加えて4時間遠流し、反応
液を減圧乾固し、残漬をクロロホルムに溶かして水、炭
酸水素ナトリウム水溶液及び水で順次洗い、芒硝で乾燥
する。溶媒を留去し、残渣をクロロホルムとエタノール
の混液から再結晶して融点250〜251’Cの徴針晶
として3−クロロメチル−9,10−ジフルオロ−7−
オキソ−2,3−ジヒドロ−7)1−ピリド[1,2,
3−del [1,4]ベンゾオキサジン−6−カルボ
ン酸エチル220mgを得た。
Dissolve 400 mg of the above compound in 30 ml of chloroform, add 3 ml of thionyl chloride, and centrifuge for 4 hours. The reaction solution is dried under reduced pressure. The residue is dissolved in chloroform, washed sequentially with water, an aqueous sodium bicarbonate solution, and water, and washed with sodium sulfate. dry. The solvent was distilled off, and the residue was recrystallized from a mixture of chloroform and ethanol to give 3-chloromethyl-9,10-difluoro-7- as needle crystals with a melting point of 250-251'C.
oxo-2,3-dihydro-7)1-pyrido[1,2,
220 mg of ethyl 3-del[1,4]benzoxazine-6-carboxylate was obtained.

上記化合物200mgを無水ベンゼン30m1に懸濁さ
せ、1.8−ジアザビシクロ[5,4,0]−7−ウン
デセン(DBU) 230mgを加えて1時間遠流する
。冷後反応液にクロロホルムを加えて水洗し、芒硝乾燥
後溶媒を留去し、残渣をシリカゲルカラムクロマトグラ
フィで精製し、ジクロルメタンとイソプロピルエーテル
の混液から再結晶して融点258〜263℃の9.10
−ジフルオロ−3−メチレン−ツーオキソ−2,3−ジ
ヒドロ−7H−ピリド[1,2,3−del [1,4
]−ベンゾオキサジン−6−カルボン酸エチル1201
11gを得た。
200 mg of the above compound is suspended in 30 ml of anhydrous benzene, 230 mg of 1,8-diazabicyclo[5,4,0]-7-undecene (DBU) is added, and the suspension is centrifuged for 1 hour. After cooling, chloroform was added to the reaction solution and washed with water. After drying with Glauber's salt, the solvent was distilled off. The residue was purified by silica gel column chromatography, and recrystallized from a mixture of dichloromethane and isopropyl ether to obtain a 9.10% solution with a melting point of 258-263°C.
-difluoro-3-methylene-twooxo-2,3-dihydro-7H-pyrido [1,2,3-del [1,4
]-ethyl benzoxazine-6-carboxylate 1201
11 g was obtained.

NMR(DMSO−da 、δppm)3位メチレン基
; 5.47.5.89(各IH,d、 J−2,5)
12) 上記化合物100+ogをジメチルスルホキシド31I
llに溶かし、N−メチルビペラジン 100mgをカ
ロえてン谷温120〜130℃で6時間攪拌する。冷後
、溶媒を減圧乾固し、残漬をシリカゲルカラムクロマト
グラフィで精製する。得られた粉末100mgをエタノ
ール10011に懸濁し、濾水酸化ナトリウム水溶液1
IIllを加えて40〜50℃で30分間攪拌する0反
応液を減圧乾固し、残漬に水を加えて希塩酸で酸性とし
たのち再び炭酸水素ナトリウムで塩基性とし、クロロホ
ルムで抽出する。抽出液は芒硝で乾燥し、溶媒を留去す
る。残渣をシリカゲルカラムクロマトグラフィで精製し
、エタノールから再結晶して融点200〜201t:の
徴針晶として9−フルオロ−10−(4−メチル−1−
ピペラジニル)−3−メチレン−7−オキソ−2,3−
ジヒドロ−7H−ピリド[1,2,3−de] [1,
4]ベンゾオキサジン−6−カルボン酸25mgを得た
NMR (DMSO-da, δppm) 3-position methylene group; 5.47.5.89 (each IH, d, J-2, 5)
12) Add 100+og of the above compound to dimethyl sulfoxide 31I
Add 100 mg of N-methylbiperazine and stir at a temperature of 120 to 130°C for 6 hours. After cooling, the solvent is dried under reduced pressure, and the residue is purified by silica gel column chromatography. 100 mg of the obtained powder was suspended in ethanol 10011, and a filtered sodium hydroxide aqueous solution 1
The reaction mixture is stirred at 40 to 50° C. for 30 minutes and dried to dryness under reduced pressure. Water is added to the residue, made acidic with dilute hydrochloric acid, made basic again with sodium bicarbonate, and extracted with chloroform. The extract was dried with Glauber's salt and the solvent was distilled off. The residue was purified by silica gel column chromatography and recrystallized from ethanol to give 9-fluoro-10-(4-methyl-1-
piperazinyl)-3-methylene-7-oxo-2,3-
Dihydro-7H-pyrido [1,2,3-de] [1,
4] 25 mg of benzoxazine-6-carboxylic acid was obtained.

NMR(CDCIs、δppm) 4.83(28,s、  2位C1,)5.26.5.
61 (各lH,d、 J−3,0)1z、3位C−C
H2)8.83 (IH,s、5位H)
NMR (CDCIs, δppm) 4.83 (28,s, 2nd place C1,) 5.26.5.
61 (each lH, d, J-3, 0) 1z, 3rd position C-C
H2) 8.83 (IH, s, 5th position H)

Claims (2)

【特許請求の範囲】[Claims] (1)式 ▲数式、化学式、表等があります▼ (式中R_1は低級アルキル基を意味する)で表わされ
る化合物
(1) Compounds represented by the formula ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ (In the formula, R_1 means a lower alkyl group)
(2)(7,8−ジフルオロ−3−メトキシメチル−2
,3−ジヒドロ−4H−1,4−ベンゾオキサジン−4
−イル)メチレンマロン酸ジエチルである特許請求の範
囲第1項の化合物
(2) (7,8-difluoro-3-methoxymethyl-2
,3-dihydro-4H-1,4-benzoxazine-4
The compound of claim 1 which is diethyl-yl)methylenemalonate.
JP20544089A 1989-08-08 1989-08-08 Benzoxazine compound Granted JPH02138268A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP20544089A JPH02138268A (en) 1989-08-08 1989-08-08 Benzoxazine compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20544089A JPH02138268A (en) 1989-08-08 1989-08-08 Benzoxazine compound

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP57112040A Division JPS591489A (en) 1982-06-29 1982-06-29 Pyridobenzoxazine derivative

Publications (2)

Publication Number Publication Date
JPH02138268A true JPH02138268A (en) 1990-05-28
JPH0331710B2 JPH0331710B2 (en) 1991-05-08

Family

ID=16506912

Family Applications (1)

Application Number Title Priority Date Filing Date
JP20544089A Granted JPH02138268A (en) 1989-08-08 1989-08-08 Benzoxazine compound

Country Status (1)

Country Link
JP (1) JPH02138268A (en)

Also Published As

Publication number Publication date
JPH0331710B2 (en) 1991-05-08

Similar Documents

Publication Publication Date Title
JPH0148911B2 (en)
JPH0692371B2 (en) Novel heterocyclic derivative, method for producing the same, and method for producing a medicine containing these and particularly useful as an aldose reductase inhibitor
JPH027314B2 (en)
JPH02138268A (en) Benzoxazine compound
JPH0116837B2 (en)
CS203184B2 (en) Process for preparing new pyrroloquinoxalinones and pyrrolobenzodiazepinones
SU554816A3 (en) The method of obtaining nitrogen-containing polycyclic compounds or their salts, or racemates, or optical antipodes
Foldeak Synthesis of analogues of cryptopleurine
US4634769A (en) Process for the preparation of 8-halo-5,6-dialkoxyquinazoline-2,4-diones and their salts
CS202069B2 (en) Method of preparing 2-/4-substituted piperazine-1-yl/-4-amino-6,7-dimethoxyquinazolines
SU639450A3 (en) Method of obtaining heterogeneous ring compounds or salts thereof
US4314939A (en) Process for the preparation of 15-hydroxyimino-E-homoeburnane and intermediates therefor
JPH0317838B2 (en)
JPH0518816B2 (en)
JPH07504678A (en) Process for producing bis-other bicyclic anxiolytics and intermediates
US3018286A (en) Methoxy-z-j
JPS6019314B2 (en) 2,3,6,7↓-tetrahydro↓-3↓-oxo↓-5H↓-pyridazino[3,4↓-b][1,4]oxazine derivative
JPS5823693A (en) Imidazoquinoxaline compounds
JPS61246188A (en) Pyrido-1,4-benzoxazine derivative
JPS5852290A (en) Pyridobenzoxazinecarboxylic acid derivative
JPS6256154B2 (en)
DK158268B (en) Procedure for production of pyridobenzoxazine-derivatives
JPH04364185A (en) Pyridobenzoxazine derivative
SU613721A3 (en) Method of obtaining heterogenous ring compounds or salts thereof
AT372948B (en) METHOD FOR PRODUCING NEW 5-SUBSTITUTED BENZO (C) -QUINOLINES

Legal Events

Date Code Title Description
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 19911112